Stay updated with breaking news from Treatment Protocol. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Ascletis Pharma Inc. (HKEX: 1672) today announces that it has submitted the marketing authorization application for ritonavir (100 mg film-coated tablet) in the Hong Kong Special
/PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672) today announces that the first sale of its ritonavir tablets in Zhejiang Province has been completed. On...
(RTTNews) - Ascletis Pharma Inc. (ASCLF.PK) announced that it has submitted marketing authorization application for ritonavir 100 mg film-coated t...
/PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672) today announces that it has submitted the marketing authorization application for ritonavir (100 mg...
Since March 1, China has recorded more than 70,000 locally transmitted COVID-19 cases, mostly caused by the highly contagious Omicron and its sub-variant, with 28 provincial-level regions affected. Epidemiologists said that such a rapid increase in cases in this short timeframe indicates the difficulty of quashing this wave quickly and returning the country to a state of zero-COVID as has been the case with previous waves.